← All trials
NCT06552260
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 28, 2025
- Primary completion
- Aug 1, 2026
- Completion date
- Aug 1, 2027
- First posted
- Aug 13, 2024
- Last posted
- Aug 14, 2024
- Enrollment
- 27
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Harvard UniversityLead sponsor
- Harvard UniversityOfficial
- National Institutes of Health (NIH)Collaborator
- Harvard UniversitySponsor investigator
- Biohaven Pharmaceuticals Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.